GHK-Cu: The Copper Peptide That Regenerates Skin, Nerves, and Tissue

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring tripeptide that binds copper with high affinity. First isolated from human plasma in 1973 by Loren Pickart, it has been the subject of over 50 years of research revealing roles in wound healing, collagen synthesis, anti-inflammatory signaling, and — most remarkably — the regulation of over 4,000 human genes.

What Is GHK-Cu?

GHK (glycyl-L-histidyl-L-lysine) is a tripeptide naturally present in human plasma, urine, and saliva. It has extremely high affinity for copper(II) ions, forming the GHK-Cu complex that constitutes its biologically active form.

Plasma GHK concentrations are highest in young adults (~200 ng/mL at age 20) and decline significantly with age (~80 ng/mL by age 60). This age-related decline correlates with reduced tissue repair capacity and slower wound healing — suggesting GHK-Cu maintains physiological regenerative capacity.

Mechanism of Action

Copper transport. GHK-Cu acts as a chaperone, delivering copper to copper-dependent enzymes including lysyl oxidase (critical for collagen and elastin crosslinking), superoxide dismutase (major antioxidant enzyme), and cytochrome c oxidase (mitochondrial electron transport).

Collagen synthesis and remodeling. Increases collagen synthesis by stimulating fibroblast activity while simultaneously activating matrix metalloproteinases (MMPs) to clear damaged collagen. This dual action — building new while clearing old — is particularly effective for healing.

Anti-inflammatory signaling. Inhibits NF-κB signaling and reduces TNF-α, IL-1β, and IL-6. Suppresses TGF-β1, a key fibrosis mediator — explaining reduced scar formation with GHK-Cu treatment.

Antioxidant effects. Both directly chelates free copper ions (preventing Fenton reaction damage) and delivers copper to antioxidant SOD.

Neurological effects. Promotes nerve regeneration, increases NGF production, and supports myelin repair. Animal studies show functional recovery in peripheral nerve injury.

The 4,000 Gene Discovery

The most striking aspect of GHK-Cu biology: it modulates expression of over 4,000 human genes — approximately 30% of genes within specific functional categories.

Key patterns: - Upregulated: Collagen synthesis, antioxidant defense, nervous system function, DNA repair, immune function, mitochondrial activity - Downregulated: Inflammation, cancer progression genes, cell death signaling, tissue destruction pathways

A 2014 analysis examined GHK’s relationship to aggressive cancer gene signatures. GHK strongly downregulated gene expression patterns associated with metastatic colon cancer — essentially reversing it toward normal tissue patterns. Similar findings emerged for lung cancer signatures.

This gene-resetting property may unify GHK-Cu’s diverse biological effects: it shifts aged or diseased tissue toward healthier, more youthful expression patterns at the genomic level.

Research Evidence

Wound Healing

• Multiple controlled studies demonstrate faster wound closure with GHK-Cu in animal models
• Human clinical studies of topical GHK-Cu show improved healing in chronic ulcers
• Increased collagen deposition and reduced infection rates documented

Skin Anti-Aging

The most commercially developed application, with controlled trials showing: - Increased skin density, thickness, and firmness - Reduction in fine lines and rough texture - Improved laxity and firmness vs. placebo - Increased production of collagen, elastin, and decorin (a key structural proteoglycan)

Neurological

Animal studies show: - Peripheral nerve regeneration after injury - Neuroprotective effects in Alzheimer’s-related models (reduced amyloid pathology, improved memory) - BDNF upregulation and synaptic support

Human neurological data is limited.

Systemic Effects

• Lung: Reduces fibrosis and inflammation in animal models
• Liver: Hepatoprotective effects in injury models
• Bone: Promotes osteoblast activity and mineralization

Forms and Administration

Topical: Best-evidenced application. GHK-Cu penetrates skin effectively. Used in cosmetics (0.05–2% concentrations) and medical wound care for decades.

Injectable (research): Lyophilized powder for reconstitution. Community protocols: - Typical dose: 0.5–2mg subcutaneous per injection - Frequency: 2–7x/week depending on goal - Often cycled 4–8 weeks on

Safety

GHK-Cu has an excellent safety record: - Naturally occurring in human plasma — not foreign - No toxicity detected in extensive animal testing - Well-tolerated in cosmetic and wound care applications over 50+ years - GHK’s copper binding actually reduces free copper toxicity vs. unbound copper - Copper toxicity theoretically possible at extreme doses, but not observed at research doses

Key Takeaways

1. Naturally occurring copper peptide that declines significantly with age, correlating with reduced regenerative capacity
2. Mechanism: copper transport to key enzymes, collagen synthesis/remodeling, anti-inflammatory signaling, antioxidant defense
3. Regulates 4,000+ genes — resetting aged/diseased expression toward healthier patterns, including reversing cancer-associated signatures
4. Best clinical evidence for topical wound healing and skin anti-aging; decades of safe cosmetic use
5. Neurological and systemic effects evidenced in animals; human clinical data limited outside dermatology
6. Unique position: combines extensive real-world cosmetic use with compelling genetic-level science